- Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T12020 | Second Faculty of Medicine
- CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia2014 | First Faculty of Medicine
- Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay2010 | Second Faculty of Medicine